Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reconsidering music in stroke rehabilitation: a scoping review from auditory stimulus to relational process.

Frontiers in psychology·2026
Same author

Recovery Yield and Defective Product Rate in a Bio-Based Amino Acid Crystallization Process.

ACS omega·2026
Same author

Additional Dose Reduction Potential of Vendor-Agnostic Deep Learning Model: A Phantom Study.

Journal of the Korean Society of Radiology·2026
Same author

Association of the planetary health diet score with obesity, high blood pressure, dyslipidemia, and cardiometabolic risk markers: Using data from the 2016-2020 Korea National Health and Nutrition Examination Survey.

PloS one·2026
Same author

Food environment and cardiovascular kidney metabolic diseases mortality.

NPJ science of food·2026
Same author

Ultraprocessed Foods and the Risk of Cognitive Impairment and Dementia in Older US Adults: 2013-2020 Health and Retirement Study.

American journal of public health·2026

Related Experiment Video

Updated: Jun 19, 2025

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
14:03

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on: March 24, 2023

1.8K

Advancing Cardiovascular Drug Screening Using Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Jisun Oh1, Oh-Bin Kwon1, Sang-Wook Park2

  • 1New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDI Hub), Daegu 41061, Republic of Korea.

International Journal of Molecular Sciences
|July 27, 2024
PubMed
Summary

Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) offer a mature model for drug testing. This platform accurately assesses cardiotoxicity and drug effectiveness by monitoring calcium dynamics, advancing preclinical drug discovery.

Keywords:
cardiomyocytescardiovascular pharmacologydrug screeninghigh-throughput assayshuman pluripotent stem cells

More Related Videos

Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids
09:23

Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids

Published on: March 10, 2023

3.7K
Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells
05:38

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Published on: February 12, 2021

4.1K

Related Experiment Videos

Last Updated: Jun 19, 2025

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
14:03

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on: March 24, 2023

1.8K
Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids
09:23

Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids

Published on: March 10, 2023

3.7K
Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells
05:38

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Published on: February 12, 2021

4.1K

Area of Science:

  • Cardiovascular Research
  • Stem Cell Biology
  • Pharmacology

Background:

  • Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) are valuable for cardiac studies but often immature.
  • A lack of high-throughput methods limits their application in drug screening.

Purpose of the Study:

  • To develop a high-throughput platform using hPSC-CMs for assessing drug cardiotoxicity and effectiveness.
  • To validate the utility of mature hPSC-CMs in drug discovery and development.

Main Methods:

  • Optimized differentiation and maturation protocols for hPSC-CMs.
  • High-throughput calcium imaging to monitor intracellular calcium dynamics.
  • Testing compounds for cardiotoxicity and effectiveness, including comparison with HEK293-hERG cells.

Main Results:

  • Mature hPSC-CMs demonstrated suitability for drug testing applications.
  • Cardiotoxic drugs (encainide, mibefradil, cetirizine) showed toxicity in hPSC-CMs, unlike in HEK293-hERG cells.
  • The platform successfully assessed drug effectiveness using a model for long QT syndrome type 3.

Conclusions:

  • Mature hPSC-CMs provide a physiologically relevant model for preclinical drug screening.
  • This high-throughput platform enhances the assessment of both cardiotoxicity and drug efficacy.
  • hPSC-CMs hold significant potential for advancing drug discovery and development.